| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 08/10/2010 | CA2237099C Sulfonylaminocarboxylic acids |
| 08/04/2010 | EP2212281A1 Arylsulfonamides with analgesic activity |
| 08/03/2010 | US7767846 including 8-hydroxypyrene-1,3,6-trislfonic acid (HPTS) and its derivatives; for analyte detection, determining blood glucose concentration |
| 07/29/2010 | WO2010049946A3 Thyroid receptor ligands |
| 07/29/2010 | WO2009153457A3 Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action |
| 07/29/2010 | US20100191475 Method for identification and functional characterization of agents which modulate ion channel activity |
| 07/29/2010 | US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases |
| 07/28/2010 | CN1939901B Method for producing 4-iod-2-aminosulfonyl-benzoic acid methyl ester |
| 07/28/2010 | CN101787024A Quinoline |
| 07/27/2010 | US7763702 Prepared by reacting a polyphosphonitrile with an amine or an alkali metal salt of an alcohol and an a perfluoroalkylsulfonylaminosulfonyl-substituted aniline or phenol salt; fuel cell membran materials |
| 07/27/2010 | US7763657 such as N-{-4-[3-(4-t-butylbenzyl)ureidomethyl]-2-vinylphenyl}methanesulfonamide, used as analgesics, and for treating psoriasis, pruritus, asthma, chronic obstructive pulmonary disease, urinary incontinence, inflammatory bowel disease, tinnitus and ischemia |
| 07/27/2010 | US7763646 beta-secretase inhibitors such as N-(3,5-difluorobenzyl)-N-{(2R)-2-hydroxy-3-[(3-iodobenzyl)amino]propyl}-5-methyl-N',N'-dipropylisophthalamide, used for reducing amyloid beta peptide formation |
| 07/27/2010 | US7763641 such as [(1S,2R)-2-hydroxy-3-[N-[4-(2-methylaminothiazol-4-yl)phenylsulfonyl]-N-(2-methylpropyl)amino]-1-(phenylmethyl)propyl]carbamic acid, [(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl]ester, used for treating human immunodeficiency virus infections |
| 07/22/2010 | WO2010083442A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | WO2010048332A3 Compounds for treating ophthalmic diseases and disorders |
| 07/22/2010 | WO2009132241A3 Proton conducting materials |
| 07/22/2010 | US20100184986 Sulfonamide-based organocatalysts and method for their use |
| 07/22/2010 | US20100184641 Novel Plasma Protein Affinity Tags |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | CA2747837A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/21/2010 | EP2207540A1 Cyclopropyl aryl amide derivatives and uses thereof |
| 07/21/2010 | CN1826310B Novel aminobenzophenone compounds |
| 07/21/2010 | CN101784520A Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 07/21/2010 | CN101781272A Method for preparing repaglinide amine and intermediate thereof |
| 07/20/2010 | CA2486399C Calcium receptor modulating agents |
| 07/20/2010 | CA2282906C Stable complexes of poorly soluble compounds |
| 07/15/2010 | WO2010051933A3 Substituted sulphonamido phenoxybenzamides |
| 07/15/2010 | WO2009111278A3 Raf inhibitor compounds and methods of use thereof |
| 07/14/2010 | EP2205091A2 Salts of 2-iodo-n-[(4-methoxy-6-methyl-1,3,5-triazine-2-yl)carbamoyl]benzenesulfonamide, method for the production thereof and use thereof as herbicides and plant growth regulators |
| 07/14/2010 | EP2205088A1 Naphthalene-based inhibitors of anti-apoptotic proteins |
| 07/13/2010 | US7754889 1,2-di(4-N,N-dimethylaminophenyl)ethylene-1,2-diamine catalyst complex for asymmetric synthesis; for producing an optically active alcohol using the catalyst to asymmetrically reduce a ketone |
| 07/13/2010 | US7754886 N-acylsulfonamide apoptosis promoters |
| 07/13/2010 | US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction |
| 07/13/2010 | CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 07/08/2010 | WO2010078449A2 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| 07/08/2010 | WO2010076033A1 Toluidine sulfonamides and their use |
| 07/08/2010 | WO2010075869A1 Toluidine sulfonamides and their use |
| 07/08/2010 | WO2010056527A3 B-biphenyl sulfonamide compounds as ion channel modulators |
| 07/08/2010 | US20100173377 N-sulfonylaminocarbonyl containing compounds |
| 07/08/2010 | CA2748607A1 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| 07/08/2010 | CA2746790A1 Toluidine sulfonamides and their use |
| 07/07/2010 | EP2203420A1 Hiv protease inhibitors |
| 07/07/2010 | CN1845894B Phenoxiacetic acid derivatives |
| 07/07/2010 | CN101768149A Novel beta- aminoketone (alkamine) derivatives and use thereof |
| 07/07/2010 | CN101768094A Method for preparing 5-amino-2-Cl-N-(2, 4-xylyl)-benzsulfamide in ionic liquid |
| 07/07/2010 | CN101768093A Preparation method of 2-carbomethoxy-5-iodobenzene sulfamide |
| 07/07/2010 | CN101768092A Preparation method of intermediate of non-steroidal anti-inflammatory drug |
| 07/06/2010 | US7750184 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; 2-(4-{1-Ethyl-1-[4-(1-hydroxy-cyclopentylethynyl)-3-methyl-phenyl]-propyl}-2-methyl-benzoylamino)-2-methyl-propionic acid |
| 07/06/2010 | CA2427429C Acylaminoalkyl-substituted benzenesulfonamide derivatives,their preparation, their use and pharmaceutical preparations comprising them |
| 07/06/2010 | CA2248242C Malononitrile-derivative anion salts, and their uses as ionic conducting materials |
| 07/01/2010 | WO2010074062A1 PROCESS FOR PRODUCING FLUOROALKYLSULFONYLAMINOETHYL α-SUBSTITUTED-ACRYLATE |
| 07/01/2010 | WO2010072831A1 Sulfurizing reagents and their use for oligonucleotides synthesis |
| 07/01/2010 | WO2010072734A2 Targeting prodrugs and compositions for the treatment of gastrointestinal diseases |
| 07/01/2010 | US20100168112 2-Substituted and 4-substituted aryl nitrone compounds |
| 07/01/2010 | US20100168070 Compounds for the treatment of alzheimer's disease |
| 07/01/2010 | US20100166706 Hcv ns-3 serine protease inhibitors |
| 07/01/2010 | CA2747999A1 Sulfurizing reagents and their use for oligonucleotides synthesis |
| 06/30/2010 | EP2202222A2 Indene derivatives, their preparation and use as medicaments |
| 06/30/2010 | EP2200969A2 Novel compounds active as muscarinic receptor antagonists |
| 06/30/2010 | EP1735270B1 Diamino alcohols and their use as renin inhibitors |
| 06/30/2010 | CN101759614A Preparation method of isothiocyanate |
| 06/30/2010 | CN101186586B N,N'-difluorophenyl derivative of 4-methoxyl-1,3-phthalamide and use thereof |
| 06/29/2010 | US7745490 3-hydroxy-N-(3-hydroxy-4-methoxyphenyl)-4-methoxybenzamide, used in the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyloidosis, such as observed non-insulin depepndent diabetes |
| 06/29/2010 | US7745441 Urokinase inhibitors |
| 06/29/2010 | US7744838 Functionalized ionic liquids, and methods of use thereof |
| 06/24/2010 | WO2010070615A1 Cysteine protease inhibitors |
| 06/24/2010 | WO2010070076A1 Alkanoic acid derivatives and their therapeutic use as hdac inhibitors |
| 06/24/2010 | WO2009140743A3 Blood imaging |
| 06/24/2010 | US20100160636 Method for producing optically active amines |
| 06/24/2010 | US20100160338 Benzenesulfonamide modulators of alpha-1a adrenergic receptors |
| 06/24/2010 | US20100160327 Modified Malonate Derivatives |
| 06/24/2010 | US20100160289 Sulfonamides as trpm8 modulators |
| 06/24/2010 | US20100158996 Ester compound and medical use thereof |
| 06/24/2010 | CA2744888A1 Cysteine protease inhibitors |
| 06/23/2010 | CN101747245A Method for preparing N, N-diethyl trifluoro-methanesulfonyl fluoride CF3SO2N (C2H5)2 by using trifluoro-methanesulfonyl fluoride |
| 06/23/2010 | CN101747244A Method for synthesizing perfluoroalkyl sulfimide alkali metal salt and ionic liquid synthesized by same |
| 06/23/2010 | CN101747243A Ionic liquid prepared through diimine (vikane) and (perfluoroalkglsulfonyl fluorosulfonyl group) imine alkali salt |
| 06/23/2010 | CN101747242A Method for preparing bi-(sulfonyl fluoride) imine and (fluorinated alkyl sulfonyl fluorine sulfonyl) imine alkali metal salt |
| 06/22/2010 | US7741520 Sulfonanilide analogs as selective aromatase modulators (SAMs) |
| 06/22/2010 | US7741362 4-amino-(S)-2-N-(4-methyl-1-naphthalenesulfonyl)amino-N'-(1,2,3,4-tetrahydro-1-naphthyl)butanamide, arylsulfonylamino based peptidomimetics used for imaging tissues and/or organs such as brain, blood vessels or tumors; medical diagnosis |
| 06/22/2010 | US7741351 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 06/22/2010 | CA2315715C Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 06/17/2010 | WO2010066847A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents |
| 06/17/2010 | WO2010028088A3 Sulfur-linked compounds for treating opthalmic diseases and disorders |
| 06/17/2010 | US20100152465 Functionalized Ionic Liquids, and Methods of Use Thereof |
| 06/17/2010 | US20100152255 Organic Compounds |
| 06/17/2010 | US20100152220 Indene derivatives as pharmaceutical agents |
| 06/17/2010 | US20100152183 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 06/17/2010 | US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 06/16/2010 | EP2196453A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-HIV agents |
| 06/16/2010 | EP2195656A2 Human t2r bitterness receptors and uses thereof |
| 06/16/2010 | CN1902165B Synthesis of optically pure (R)-5-(2-aminopropyl)-2-methoxybenzenesulphonamide |
| 06/16/2010 | CN101735117A Preparation method of o-aminosulfonyl-benzoyl hydrazine |
| 06/15/2010 | US7737295 1-benzyl-4-[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]imidazolidin-2-one; cholesteryl ester transfer protein inhibitor; raising HDL-cholesterol, reducing LDL-cholesterol; atherosclerosis, antiinflammatory agent; synergistic mixture with other active ingredients |
| 06/15/2010 | US7737139 useful in inhibiting the chernotactic activation of neutrophils, induced by the interaction of Interleukin-8 (IL-8) with chemokine membrane receptors |
| 06/15/2010 | CA2432053C Method for fluorinating a compound comprising a halosulphonyl or dihalophosphonyl group |
| 06/10/2010 | WO2010028968A3 Polymorphs of acyl sulfonamides |
| 06/10/2010 | WO2010018109A3 Substituted aminotetralines |
| 06/10/2010 | US20100145056 Acetyl 2-hydroxy-1,3-diaminoalkanes |
| 06/10/2010 | US20100144762 Novel sulfonamides as l-cpt1 inhibitors |